Abstract
In this issue of Blood, Yeomans et al identify MYC as an important target for translational regulation in chronic lymphocytic leukemia (CLL) cells after B-cell receptor (BCR) stimulation and show that current therapies suppress this induction.
Original language | English |
---|---|
Pages (from-to) | 378-380 |
Number of pages | 3 |
Journal | Blood |
Volume | 127 |
Issue number | 4 |
DOIs | |
Publication status | Published - 28 Jan 2016 |